HRT Financial’s KalVista Pharmaceuticals KALV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-68,778	Closed	-$676K	–	2988
2022 Q2	$676K	Buy	+68,778	New	+$676K	0.01%	1244
2021 Q4	–	Sell	-27,296	Closed	-$476K	–	3316
2021 Q3	$476K	Buy	+27,296	New	+$476K	﹤0.01%	1843